Avinger Announces Second Quarter 2017 Results
Aug 08, 2017 20:01 pm UTC| Business
REDWOOD CITY, Calif., Aug. 08, 2017 -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the second quarter ended...
Aug 08, 2017 20:01 pm UTC| Business
SEATTLE and FREMONT, Calif., Aug. 08, 2017 -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and Lam Research Corporation...
Celldex Reports Second Quarter 2017 Results
Aug 08, 2017 20:01 pm UTC| Business
HAMPTON, N.J., Aug. 08, 2017 -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the second quarter ended June 30, 2017. "In the second quarter, we continued to see strong...
Monroe Capital Corporation BDC Announces Second Quarter Financial Results
Aug 08, 2017 20:01 pm UTC| Business
CHICAGO, Aug. 08, 2017 -- Monroe Capital Corporation (Nasdaq:MRCC) (“Monroe”) today announced its financial results for the second quarter ended June 30, 2017. Except where the context suggests otherwise, the terms...
Nuvectra™ Reports Second Quarter 2017 Financial Results
Aug 08, 2017 20:01 pm UTC| Business
PLANO, Texas, Aug. 08, 2017 -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today announced financial results for the second quarter ended June 30, 2017. Highlights Record...
Achaogen to Present at the Wedbush PacGrow Healthcare Conference
Aug 08, 2017 20:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2017 -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...
Ohr Pharmaceutical Announces Fiscal Third Quarter 2017 Earnings
Aug 08, 2017 20:01 pm UTC| Business
NEW YORK, Aug. 08, 2017 -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported results for its fiscal third quarter ended...